Skip to main content

Table 1 Distribution of positive final immunohistochemical score of monocarboxylate transporters (MCTs) and CD147 in adjacent non-tumoural (NT) and tumour tissue (T) of prostate samples

From: Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer

   

ISG (%)

 

HSG (%)

 
 

n

(Score 4)

p

(Scores 5-6)

p

MCT1

   

0.500

 

0.002

 

NT

121

17.4

 

66.9

 
 

T

166

18.0

 

46.4

 

MCT2

   

0.048

 

< 0.001

 

NT

132

37.9

 

16.7

 
 

T

166

26.0

 

53.0

 

MCT4

   

0.474

 

< 0.001

 

NT

128

16.4

 

7.8

 
 

T

168

20.8

 

23.2

 

CD147

   

0.211

 

0.153

 

NT

134

11.9

 

41.1

 
 

T

167

16.7

 

32.9

 
  1. ISG, intermediate score group; HSG, high score group.